Insmed revenue and financials
$105.23Change from previous close: +1.35%Absolute change: +$1.40
In the fiscal year ended December 2025, Insmed reported revenue of $606.42M (+66.73% year over year). The net loss was $1.28B.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +66.73%
- 2025 vs 2024
- Net margin
- -210.5%
- 2024: -251.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,265 | 2,025 | 1,330 | 1,656 | 1,244 | 796 | 742 | 605 | 462 | 238 |
| Current assets | 1,794 | 1,622 | 929 | 1,273 | 837 | 623 | 555 | 519 | 389 | 168 |
| Cash and equivalents | 510 | 555 | 482 | 1,074 | 717 | 533 | 487 | 495 | 381 | 163 |
| Short-term investments | 920 | 879 | 298 | 74.2 | — | — | — | — | — | — |
| Receivables | 141 | 52.0 | 41.2 | 29.7 | 24.4 | — | — | — | — | — |
| Inventory | 132 | 98.6 | 83.2 | 69.9 | 67.0 | — | — | — | — | — |
| Net property, plant and equipment | 139 | 116 | 104 | 102 | 95.5 | — | — | — | — | — |
| Goodwill | 136 | 136 | 136 | 136 | 136 | — | — | — | — | — |
| Other intangible assets | 74.6 | 30.8 | 31.0 | 31.2 | 31.4 | — | — | — | — | — |
| Long-term investments | — | — | — | 0.0 | 50.0 | — | — | — | — | — |
| Current liabilities | 469 | 298 | 226 | 190 | 135 | 119 | 85.2 | 79.7 | 44.7 | 28.0 |
| Accounts payable | 79.9 | 73.0 | 65.4 | 50.5 | 35.8 | — | — | — | — | — |
| Long-term debt | 547 | 1,122 | 1,178 | 1,154 | 800 | 450 | 450 | 450 | 55.0 | 55.0 |
| Total debt | 587 | 1,149 | 1,204 | 1,178 | — | — | — | — | — | — |
| Total liabilities | 1,526 | 1,740 | 1,662 | 1,568 | 833 | 520 | 481 | 396 | 101 | 83.5 |
| Total equity (incl. minority) | 739 | 285 | -332 | 88.0 | 410 | — | — | — | — | — |
| Retained earnings | -5,637 | -4,360 | -3,446 | -2,697 | -2,265 | — | — | — | — | — |